Related Experiment Videos
Cyanoacrylate adhesive provides efficient local drug delivery
Metin Manouchehr Eskandari1, Ozlem Goruroglu Ozturk, Hatice Gulcin Eskandari
1Department of Orthopaedics and Traumatology, University of Mersin, School of Medicine, Mersin, Turkey. askandari@mersin.edu.tr
Clinical Orthopaedics and Related Research
|June 9, 2006
Summary
This study explores n-butyl-2-cyanoacrylate as a low-cost, biodegradable material for drug delivery. The developed implant effectively releases vancomycin for extended periods, showing promise for musculoskeletal treatments.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Musculoskeletal Therapeutics
Background:
- Biodegradable implants are crucial for musculoskeletal treatments but often costly and unavailable.
- N-butyl-2-cyanoacrylate, a common tissue adhesive, is investigated as an alternative drug-trapping material.
- Absorbable gelatin sponge serves as a scaffold for the drug-eluting implant.
Purpose of the Study:
- To evaluate n-butyl-2-cyanoacrylate as an inexpensive, biodegradable scaffold for local drug delivery.
- To assess the in vitro and in vivo drug release kinetics of vancomycin from the proposed implant.
- To determine the local inflammatory response associated with the n-butyl-2-cyanoacrylate implant in vivo.
Main Methods:
- A mouse muscle pouch model was utilized for in vivo drug release and inflammatory response studies.
- Vancomycin release was quantified using fluorescence polarization immunoassay.
- Inflammatory response was assessed via leukocyte count and a grading system.
Main Results:
- The n-butyl-2-cyanoacrylate implant demonstrated sustained vancomycin release up to 42 days in vitro and 14 days in vivo.
- A local inflammatory response was observed, which diminished over 3 weeks in groups with lower adhesive concentrations.
- The material effectively traps and facilitates slow drug release, indicating potential as a biodegradable drug delivery device.
Conclusions:
- N-butyl-2-cyanoacrylate shows potential as a cost-effective and accessible biodegradable material for local drug delivery in musculoskeletal applications.
- The developed implant offers prolonged drug release, addressing limitations of current systems.
- Further research into optimizing adhesive concentration can mitigate inflammatory responses, enhancing clinical applicability.